KIM LLC’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-660,000
Closed -$44.9M 869
2022
Q3
$44.9M Buy
+660,000
New +$36.4M 2.09% 6

Other funds holding GBT

KIM LLC's GBT Position: Q4 2022 in Review

KIM LLC sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 660,000 shares — an estimated $44.9M sold.

KIM LLC first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $44.9M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • KIM LLC reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • KIM LLC sold 660,000 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $44.9M.
  • KIM LLC first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
  • KIM LLC's Global Blood Therapeutics, Inc. position peaked at $44.9M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on KIM LLC's 13F filing for Q4 2022, filed 14 Feb 2023.